Arciniegas, DB (2015). Psychosis. Continuum (Minneapolis, Minn.), 21, 715–736.
Auquier, P, Lancon, C, Rouillon, F, Lader, M (2007). Mortality in schizophrenia. Pharmacoepidemiology and Drug Safety, 16, 1308–1312.
Baldwin, P, Browne, D, Scully, PJ, Quinn, JF, Morgan, MG, Kinsella, A, Owens, JM, Russel, V, O’Callaghan, E, Waddington, JL (2005). Epidemiology of first-episode psychosis: illustrating the challenges across diagnostic boundaries through the Cavan-Monaghan study at 8 years. Schizophrenia Bulletin, 31, 624–638.
Barnes, TRE, Bhatti, SF, Adroer, R, Paton, C (2015). Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK. BMJ Open, 5, e007633.
Bird, V, Premkumar, P, Kendall, T, Whittington, C, Mitchell, J, Kuipers, E (2010). Early intervention services, cognitive–behavioural therapy and family intervention in early psychosis: systematic review. The British Journal of Psychiatry, 197, 350–356.
Blanchard, JJ, Brown, SB (1998). 4.05 – Structured diagnostic interview schedules. In Comprehensive Clinical Psychology (ed. Bellack, A. S. and Hersen, M.). Oxford: Pergamon.
BNF (2011). British National Formulary (BNF) British Medical Association and the Royal Pharmaceutical Society of Great Britain. London: Pharmaceutical Press.
Byrne, P (2007). Managing the acute psychotic episode. BMJ (Clinical research ed.), 334, 686–692.
Cantwell, R, Brewin, J, Glazerbrook, C, Dalkin, T, Fox, R, Medley, I, Harrison, G (1999). Prevalence of substance misuse in first-episode psychosis. The British Journal of Psychiatry, 174, 150–153.
Castillo, R, Carlat, D, Millon, T, Millon, C, Meagher, S, Grossman, S, Rowena, R, Morrison, J, Association, AP (2007). Diagnostic and statistical manual of mental disorders, Washington, DC: American Psychiatric Association Press.
Cavalcante, D, Ortiz, B, Noto, M, Cordeiro, Q, Coutinho, L, Ota, V, Belangero, S, Bressan, R, Gadelha, A, Noto, C (2018). Duration of Untreated Psychosis (DUP) is associated with worse response to treatment in antypsychotic naive first episode psychosis. Schizophrenia Bulletin, 44(suppl_1), S96.
Clarke, AM, Mclaughlin, P, Staunton, J, Kerins, K, Power, B, Kearney, K, MCcguinness, M, Whitty, P (2017). Retrospective study of first episode psychosis in the Dublin Southwest Mental Health Service: demographics, clinical profile and service evaluation of treatment. Irish Journal of Psychological Medicine, 34, 1–10.
Geoff, S, Michael, P (2011). Measuring the costs and benefits of promoting social inclusion. Mental Health and Social Inclusion, 15, 165–174.
Heckers, S (2009). Who is at risk for a psychotic disorder? Schizophrenia Bulletin, 35, 847–850.
Higashi, K, Medic, G, Littlewood, KJ, Diez, T, Granstrom, O, De Hert, M (2013). Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic advances in psychopharmacology, 3, 200–218.
Ising, HK, Smit, F, Veling, W, Rietdijk, J, Dragt, S, Klaassen, RMC, Savelsberg, NSP, Boonstra, N, Nieman, DH, Linszen, DH, Wunderink, L, Van Der Gaag, M (2014). Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial. Psychological Medicine, 45, 1435–1446.
Miller, JT, Mcglashan, T, Rosen, LJ, Cadenhead, K, Cannon, T, Ventura, J, Mcfarlane, W, Perkins, D, Pearlson, G, Woods, S (2003). Prodromal Assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability. Schizophrenia Bulletin, 29, 703–715.
Jones, S, Howard, L, Thornicroft, G (2008). ‘Diagnostic overshadowing’: worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica, 118, 169–171.
Spitzer, LR, Williams, J, Gibbon, M, First, M (1990). User’s guide for the structured clinical interview for DSM-IV Axis II personality disorders (SCID-II). Washington DC, American Psychiatric Press.
Laursen, TM, Nordentoft, M, Mortensen, PB (2014). Excess early mortality in schizophrenia. Annual Review of Clinical Psychology, 10, 425–448.
Lloyd-Evans, B, Crosby, M, Stockton, S, Pilling, S, Hobbs, L, Hinton, M, Johnson, S (2018). Initiatives to shorten duration of untreated psychosis: systematic review. British Journal of Psychiatry, 198, 256–263.
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry, 62, 975–983.
Marshall, M, Rathbone, J (2011). Early intervention for psychosis. The Cochrane Database of Systematic Reviews, CD004718–CD004718.
Mcfarlane, WR, Levin, B, Travis, L, Lucas, FL, Lynch, S, Verdi, M, et al. (2015). Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. Schizophrenia Bulletin, 41, 30–43.
NICE (2014). Psychosis and schizophrenia in adults: prevention and management. National Institute for Healthcare and Excellence. [Online] (https://www.nice.org.uk/guidance/cg178). Accessed 10 April 2018.
Osterberg, L, Blaschke, T (2005). Adherence to medication. New England journal of medicine, 353, 487–497.
Pentillä, M, Jääskeläinen, E, Hirvonen, N, Isohanni, M, Miettunen, J (2014). Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. The British Journal of Psychiatry, 205, 88–94.
Perez, J, Jin, H, Russo, DA, Stochl, J, Painter, M, Shelley, G, Jackson, E, Crane, C, Graffy, JP, Croudace, TJ, Byford, S, Jones, PB (2015). Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial. The Lancet Psychiatry, 2, 984–993.
Randall, JR, Vokey, S, Loewen, H, Martens, PJ, Brownell, M, Katz, A, Nickel, NC, Burland, E, Chateau, D (2015). A systematic review of the effect of early interventions for psychosis on the usage of inpatient services. Schizophrenia Bulletin, 41, 1379–1386.
Read, J, Van Os, J, Morrison, AP, Ross, CA (2005). Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatrica Scandinavica, 112, 330–350.
Reininghaus, U, Dutta, R, Dazzan, P, Doody, GA, Fearon, P, Lappin, J, Heslin, M, Onyejiaka, A, Donoghue, K, Lomas, B, Kirkbride, JB, Murray, RM, Croudace, T, Morgan, C, Jones, PB (2015). Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ÆSOP first-episode cohort. Schizophrenia Bulletin, 41, 664–673.
Rodrigues, R, Anderson, KK 2017. The traumatic experience of first-episode psychosis: a systematic review and meta-analysis. Schizophrenia Research, 189, 27–36.
Scully, PJ, Quinn, JF, Morgan, MG, Kinsella, A, O’Callaghan, E, Owens, JM, Waddington, JL (2002). First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan–Monaghan study at 5 years. The British Journal of Psychiatry, 181, s3–s9.
Segal, DL, Hersen, M, Van Hasselt, VB (1994). Reliability of the structured clinical interview for DSM-III-R: an evaluative review. Comprehensive Psychiatry, 35, 316–327.
Thornicroft, G (2011). Physical health disparities and mental illness: the scandal of premature mortality. The British Journal of Psychiatry, 199, 441–442.
Tsiachristas, A, Thomas, T, Leal, J, Lennox, BR (2016). Economic impact of early intervention in psychosis services: results from a longitudinal retrospective controlled study in England. BMJ Open, 6, e012611.
Wahlbeck, K, Westman, J, Nordentoft, M, Gissler, M, Laursen, TM (2018). Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. British Journal of Psychiatry, 199, 453–458.